New Weapon Against Hard-to-Treat Bacterial Infections
News Sep 28, 2016
Health workers may soon have a new weapon in the fight against abscesses; difficult-to-treat bacterial infections that lead to millions of emergency-room visits every year.
Researchers at the University of British Columbia successfully prevented drug-resistant bacteria from forming abscesses, or painful pus-filled lesions, using a peptide, or mini-protein. The peptide worked by disrupting the bacteria’s stress response.
Abscesses are bacterial-induced lesions that are responsible for 3.2 million emergency room visits every year in the United States. Because antibiotics seldom work on them, standard treatment for abscesses involves cutting out the infected tissue or draining it.
“Abscesses can occur almost anywhere in the body, and antibiotics aren’t usually effective on them,” said senior author Bob Hancock, a professor in UBC’s department of microbiology, and senior author of the study published in EBioMedicine. “Our peptide offers a new strategy, because its mechanism is completely different from every known antibiotic.”
Hancock and his colleagues discovered that bacteria in abscesses are in a stress-triggered growth state. Using a synthetic peptide known as DJK-5, they were able to interfere with the bacteria’s stress response and heal abscesses in mice. The peptide was effective against two classes of bacteria, known as Gram-positive and Gram-negative bacteria, whose different cell-wall structures make them susceptible to different antibiotics.
“We’ve shown that all of the superbugs are susceptible to this peptide when under stress,” said Hancock. “We also showed that it actually works even better in the presence of antibiotics. By combining antibiotics with the peptide there is a much lower chance of getting resistance, because you’ve got two agents that act in different ways.”
Computation and Chemistry Combine to Create World-First Auxetic ProteinNews
A team of chemists at the University of California, San Diego (UCSD) has now designed a two-dimensional protein crystal that toggles between states of varying porosity and density. This is a first in biomolecular design that combined experimental studies with computation done on supercomputers. The research, published in April 2018 in Nature Chemistry, could help create new materials for renewable energy, medicine, water purification, and more.
Fructose Formula Poses Risk to Babies With Metabolic DisorderNews
Babies with inherited intolerance of fructose face a risk of acute liver failure if they are fed certain widely available formulas containing fructose, pediatricians and geneticists are warning. Baby formula manufacturers should remove fructose or sucrose, or explicitly label their products to allow parents to avoid those sweeteners if necessary, the doctors say.
Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing SitesNews
Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S.READ MORE